Research Beam added a report on “Rheumatoid Arthritis - Pipeline Review, H1 2015” Enquiry about report: http://www.researchbeam.com/rheumatoid-arthritis-pipeline-review-h1-2015-market/enquire-about-report

1. Rheumatoid Arthritis -
Pipeline Review, H1
2015
TELEPHONE: +1 (503) 894-6022
E-MAIL: sales@researchbeam.com

2. Report Overview
Scope
- The report provides a snapshot of the global therapeutic landscape of Rheumatoid Arthritis
- The report reviews key pipeline products under drug profile section which includes, product
description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Rheumatoid Arthritis and
enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Rheumatoid Arthritis products under development by companies and
universities/research institutes based on information derived from company and industry-specific
sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till
discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Rheumatoid Arthritis pipeline on the basis of target, MoA, route of administration
and molecule type
- Latest news and deals relating related to pipeline products
Read More At : http://www.researchbeam.com/rheumatoid-arthritis-pipeline-review-h1-2015-market

3. Table of Content
Table of Contents 2
Introduction 12
Rheumatoid Arthritis Overview 13
Therapeutics Development 14
Rheumatoid Arthritis - Therapeutics under Development by Companies 16
Rheumatoid Arthritis - Therapeutics under Investigation by Universities/Institutes 36
Rheumatoid Arthritis - Pipeline Products Glance 40
Rheumatoid Arthritis - Products under Development by Companies 44
Rheumatoid Arthritis - Products under Investigation by Universities/Institutes 72
Rheumatoid Arthritis - Companies Involved in Therapeutics Development 75
Rheumatoid Arthritis - Therapeutics Assessment 291
Drug Profiles 324
Rheumatoid Arthritis - Recent Pipeline Updates 892
Rheumatoid Arthritis - Dormant Projects 1027
Rheumatoid Arthritis - Discontinued Products 1063
Rheumatoid Arthritis - Product Development Milestones 1074
Appendix 1087

4. Report Overview
- Provides strategically significant competitor information, analysis, and insights to formulate effective
R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-
strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for
Rheumatoid Arthritis
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Rheumatoid Arthritis pipeline depth
and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with
the most attractive projects to enhance and expand business potential and Scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors
that drove them from pipeline
Enquire At : http://www.researchbeam.com/rheumatoid-arthritis-pipeline-review-h1-2015-
market/enquire-about-report

5. FOR MORE DETAILS
Visit us at :
Stay With Us:
http://www.researchbeam.com/rheumatoid-arthritis-pipeline-review-h1-2015-market
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
TELEPHONE: +1 (800) 910-6452
DIRECT: +1 (503) 894-6022
E-MAIL: sales@researchbeam.com